Laboratory of Neurogeriatrics

LABORATORY OF NEUROGERIATRICS

Robert P. Friedland, MD

select from the list to see details:

Education

Postgraduate Training

Professional Certification

Professional Activities

Community Advisory Activities

Extramural Advisory and Editorial Activities

Extramural and Intramural Research Support and Awards

Educational Activities

Membership in Professional Organizations

Committees

PUBLICATIONS

click here to access complete list of publications, abstracts and presentations

EDUCATION:

City College of New York, New York Degree: B.S., Biology	1965-69
University of Kentucky College of Medicine Lexington, Kentucky	1969-71
Summer Fellowship in Neurology, Department of Neurology Boston University School of Medicine, Boston, MA	1970
Mount Sinai School of Medicine City University of New York, New York, NY	1971-73
M.D.	June 1973

top

POSTGRADUATE TRAINING:

Straight Medicine Internship Beth Israel Hospital, New York, New YorK	1973-74
Neurology Residency and Chief Residency Mount Sinai School of Medicine, New York, New York	1974-77
Weatherhead School of Management, CWRU
Member, Professional Fellows Program (15 credits)	1992-1993
Banking & Finance 420: Health Finance & Economics (3 credits)	1993
Health Systems Management 456: Issues in Health Management (3 credits)	1994

top

PROFESSIONAL CERTIFICATION:

Diplomate, National Board of Medical Examiners	1974
Certified, American Board of Psychiatry and Neurology	1979
California, Physician and Surgeon (GO 39005)	1980-1995
California, Physician and Surgeon (GO 39005)	1986-91
Maryland, Physician and Surgeon (D33237)	1988-91
District of Columbia, Medicine and Surgery (17144)	1988-91
Ohio, Doctor of Medicine (35-05-9810)	1990-Present

top

PROFESSIONAL ACTIVITIES:

Research Fellow, National Institutes of Health (Senile Dementia: Biological and Behavioral Aspects) Albert Einstein College of Medicine, New York, New York	1977-78
Associate, Department of Neurology Albert Einstein College of Medicine, New York, New York Clinical Study of Aging, Dementia and Cerebral Blood Flow (133 Xe Inhalation)	1977-78
Assistant Attending Neurologist Lincoln Hospital, Bronx, New York	1977-78
Clinical Fellow Jacobi Hospital, Department of Neurology, Bronx, New York	1977-78
Assistant Professor of Neurology, in Residence University of California, Davis	1978-85
Associate Professor of Neurology, in Residence University of California, Davis	1985
Staff Neurologist Veterans Administration Medical Center, Martinez, California	1978-85
Assistant Chief, Neurology Service Veterans Administration Medical Center, Martinez, California	1978-84
Attending Neurologist, Highland General Hospital Oakland, California	1979-85
Guest Scientist, Donner Laboratory University of California, Berkeley	1979-85
Chief Neurologist Research Medicine Group Donner Laboratory University of California, Berkeley	1982-85
Director and Founder, Northern California Alzheimer's Disease Center, University of California Davis, Berkeley, California	1985
Chief, Brain Aging and Dementia Section Laboratory of Neurosciences, National Institute on Aging, NIH	1986-1990
Deputy Clinical Director National Institute on Aging	1986-1990
Clinical Professor Department of Neurology Georgetown University School of Medicine	1988-1990
Director, Alzheimer's Disease and Memory Disorders Clinic Georgetown University Hospital	1988-1990
Clinical Director	1990-1993
Acting Director	1993
Associate Director NIA Alzheimer's Disease Research Center University Hospitals of Cleveland	1994
Associate Professor	1990-2001
Professor Departments of Neurology, Psychiatry and Radiology Case Western Reserve University School of Medicine	2001-present
Chief, Laboratory of Neurogeriatrics Department of Neurology Case Western Reserve University School of Medicine	1994-Present

top

COMMUNITY ADVISORY ACTIVITIES:

Medical Advisor and Member, Board of Directors Alzheimer’s Aid Society of Northern California	1983-85
Member, Scientific Advisory Committee Family Survival Project, San Francisco	1984-1995
Chief Witness, California Assembly Select Committee on Mental Health, Hearing on "Organic Brain Syndromes," State Capital, Sacramento	1984
Member, Ad Hoc Committee to Consider a National Conference on Neurological Disease and Aging, Special Committee on Aging, U.S. Senate	1986
Consultant, WNET/Thirteen, New York	1988
Member, Neuroscience Advisory Panel, Conte Institute for Environmental Health, Pittsfield, MA	1993-1994
Consultant, Dementia and Driving Consensus Meeting, Swedish National Road Administration, Borlange	1994

top

EXTRAMURAL ADVISORY AND EDITORIAL ACTIVITIES:

Ad Hoc Reviewer of Research Programs
Research Service, VA Central Office	1984, 1986, 1988, 1989, 1991, 1993-95
Division of Research Grants, NIH	1987-1995, 1997, 1998
Human Frontier Science Program(EEC, Strasbourg)	1991, 1991-1993,1997
Edison Biotechnology Center	1992
Retirement Research Foundation	1993
Netherlands Organization for Scientific Research	1994
Alzheimer Association	1994, 1996-1999
British Columbia Health Research Foundation	1995, 1999
American Federation for Aging Research	1995-present
The National Institute for Psychobiology in Israel	1998, 2002
Special Emphasis Panel, NIH, CSR	1998
Warrant Committee, Italian Ministry of Research	1998
Douglas French Foundation, Los Angeles	2002

top

Ad Hoc Referee of Submitted Manuscripts and Proposals

Agency for Health Care Policy and Research (DHHS)

1994

Annals of Neurology

1993-1995

Archives of Neurology

1986-1989, 1992,1997,2001-2004

Biological Psychiatry

1989-1991

Brain Research

1987, 1993

Investigative Radiology

1995

Journal of the American Geriatrics Society

1999

Journal of the American Medical Association

1991-1998,2000, 2002,2003

Journal of Cerebral Blood Flow and Metabolism

1987, 1988, 1992-1994

Journal of Computer Assisted Tomography

1987

Journal of Geriatric Psychiatry and Neurology

1991, 1996

Journal of Neuroimmunology

1999

Journal of Nuclear Medicine

1993-1996,1998,1999, 2002

Lancet Neurology

Nature Biotechnology

Nature Medicine

2004

2001

2000

Neurobiology of Aging

1991-1993, 1999

Neuroepidemiology

2002

Neurology

1988-1997,2002

Neurology Network Commentary

1997

Proceedings of the National Academy of Sciences

Scanning Microscopy International

2001

1994

Science

1984, 1985

Seminars in Neurology

1998, 1999

top

Member, Alzheimer's Disease Review Panel Department of Health Services State of California

1985

Member, Editorial Board Alzheimer's Disease: an International Journal

1985-1994

Member, Scientific Program Committee, IX European

International Neuropsychology Society Conference, Veldhoven

1986

Member, Scientific Program Committee (Neurology) Annual Meeting of the Society for Nuclear Medicine, Washington, D.C.

1986,1989

Office of Medical Applications of Research

NIH Planning Committee: Consensus Development Conference on Nuclear Magnetic Resonance Imaging

1986-87

Temporary Advisor, Division of Mental Health

World Health Organization, Geneva, Switzerland

1987

Temporary Advisor, Division of Mental Health

World Health Organization, Beijing, China

1987

Consultant, World Health Organization Special Program for Research on Aging, Bethesda, MD.

1988

Consultant, "Cooperative Studies of Alzheimer's Disease in U.S. and Japan," National Institute of Neuroscience, National Center for Neurology and Psychiatry, Tokyo

1989

American Neurological Association, Representative

to the National Coalition for Research in Neurological Disorders

1991-1997

Consultant for Review of Drug Development

    Ayerst, Inc

1986

    Miles Pharmaceuticals

1991

    Astra Zeneca

    Quintiles Pacific, Inc

1999

2000

Consortium to Establish a Registry for Alzheimer's Disease (CERAD) (NIH) Clinical Task Force

1991-1996

Reviewer - Agency for Health Care Policy and Research (DHHS) Panel on recognition and initial assessment of Alzheimer's disease and related dementias

1994

Symposium Co-Organizer: "Neurodegenerative Disorders: Common Molecular Mechanisms", Ocho Rios, Jamaica, Goteborg University and University of the British West Indies

March 1994

March 1995

March 1997

February 1998

Symposium Co-Organizer: "Neurodegenerative Disorders: Common Molecular Mechanisms," University of the British West Indies, Trinidad

April, 2000

Medical and Scientific Advisory Board

Alzheimer's Association, Chicago (Ad hoc member)

1994

Symposium Co-Organizer: The Second Tel Aviv University Alzheimer's Disease Conference-Joint meeting with Case Western Reserve University (Supported by the Joseph & Florence Mandel Foundation, Cleveland, OH, Tel Aviv University, the NIA, and Philip Morris)($81,000)

May 1995

Consultant, Alzheimer’s disease and fitness for driving,

Association for the Advancement of Automotive Medicine, National Highway Safety Administration, Sweden

1996

Consultant, Monitor/Tracker for Alzheimer’s disease, PI. R. Schmidt Cleveland Medical Devices Corporation NIH/SBIR

1996-1999

Member, American Federation for Aging Research,

National Scientific Advisory Council

1996-present

Member, Review Board of the Medical and Scientific Advisory Council, Ronald and Nancy Reagan Research Institute, Alzheimer’s Association

1997-present

Member, Scientific Advisory Committee, National Institute for Psychobiology, Israel

1999-present

Panel member, Workshop on Alzheimer’s Disease Epidemiology

Beethesda, NIH, National Institute on Aging

March, 1998

Consultant for Alzheimer’s disease drug studies and biomarkers

      Chrysalis Corporation, (Contract Research Organization)

      Austin, Texas

1997-1999

      Pfizer, Inc.

2000

Member, International Advisory Board, "Vascular Factors in Alzheimer’s Disease”,

International Meeting, Northumberland, UK

May, 1999

Member, Special Emphasis Panel ZRG1 BDCN2(02)

NIH Center for Scientific Review

October, 1999

Member, Neuroscience of Aging Review committee,

NIA Initial Review Group, NIH

June, 2000

Member, Scientific Review Board, Institute

for the Study of Aging, New York

1999-present

Associate Editor and member, Editorial Board,

Journal of Alzheimer’s Disease

1999-2002

Principal Organizer, "First International Symposium on Alzheimer’s Disease in the Middle East”, Limassol, Cyprus

April, 2001

Reviewer, Human Frontiers Science Program, Strasbourg

1999-2000

Member, Initial Review Board of the Medical and Scientific Advisory Council, Alzheimer’s Association

1999- present

Member, International Scientific Committee

Third World Congress on Vascular Factors in Alzheimer’s Disease

Kyoto

April, 2002

Principal Organizer, "First International Symposium on Alzheimer’s Disease in the Middle East”, Limassol

April, 2001

Principal Organizer, "Second International Symposium on Alzheimer’s Disease in the Middle East” Istanbul

External Reviewer, Michael Smith Foundation for Medical Research, Vancouver

  May, 2003

2001,

2002

Member, International Coordinating Committee, and Founding Member, International Society for Vascular Behavioral and Cognitive Disorders (VAS-COG), First Meeting, Goteborg

August, 2003

Reviewer, State of Missouri Alzheimer’s Disease and Related Disorders Advisory Board

Member, Middle East Academy for Medicine of Ageing, Beirut

Member, Editorial Advisory Board, Current Alzheimer Research

Member, International Scientific Advisory Board, Alzheimer’s Disease International, Annual Meeting, Istanbul

Principal Organizer, Third International Symposium on Alzheimer’s Disease in the Middle East, Istanbul

2003

  2003- present

2004-present

October, 2005

October, 2005

top

EXTRAMURAL AND INTRAMURAL RESEARCH SUPPORT AND AWARDS:

Principal Investigator, "Effect of activation of ischemic neurons on recovery from stroke", University of California, Davis, Faculty Research Grant	1979-81
Principal Investigator, VA Merit Review Research Program, "Cerebral Metabolic Indices of Dementia Pathophysiology"	1981-84
Principal Investigator, (Renewal of above Program) "Structural and Functional Indices of Dementia Pathophysiology" ($47,337/year)	1984-85
Co-Investigator, "Ischemic Brain Disease," (NIH HL 25840), ($34,192/year), Principal Investigator, Philip Weinstein, M.D.	1983-85
Co-Investigator "Cerebral blood flow patterns in Alzheimer's disease", (NIH), ($187,000/year) Principal Investigator, Thomas F. Budinger, M.D., Ph.D.	1985
Principal Investigator, "Oxiracetam in the treatment of progressive degenerative dementia of mild to moderate severity", Ciba-Geigy Corporation ($67,000)	1985
Project Director and Founder "Northern California Alzheimer's Disease Center," Department of Health Services, State of California ($100,000/year)	1985
Chief, Brain Aging and Dementia Section National Institute on Aging, NIH ($2.4 million/year)	1986-1990
Director, Clinical Core	1990-1993
Acting Director	1993
Co-Director Clinical Core Alzheimer's Disease Research Center University Hospitals of Cleveland NIA AG08012 ($1,386,582/year)